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Identification of a hybrid myocardial zone in the
mammalian heart after birth
Xueying Tian1,2, Yan Li1,2, Lingjuan He1,2, Hui Zhang2,3, Xiuzhen Huang1,2, Qiaozhen Liu1,2, Wenjuan Pu1,2,
Libo Zhang1,2, Yi Li1,2, Huan Zhao1,2, Zhifu Wang4, Jianhong Zhu4, Yu Nie5, Shengshou Hu5, David Sedmera6,
Tao P. Zhong7, Ying Yu2,8, Li Zhang9, Yan Yan10, Zengyong Qiao11, Qing-Dong Wang 12, Sean M. Wu13,
William T. Pu14,15, Robert H. Anderson16 & Bin Zhou1,2,3,17
Noncompaction cardiomyopathy is characterized by the presence of extensive trabeculations,
which could lead to heart failure and malignant arrhythmias. How trabeculations resolve to
form compact myocardium is poorly understood. Elucidation of this process is critical to
understanding the pathophysiology of noncompaction disease. Here we use genetic lineage
tracing to mark the Nppa+ or Hey2+ cardiomyocytes as trabecular and compact components
of the ventricular wall. We find that Nppa+ and Hey2+ cardiomyocytes, respectively, from the
endocardial and epicardial zones of the ventricular wall postnatally. Interposed between these
two postnatal layers is a hybrid zone, which is composed of cells derived from both the Nppa+
and Hey2+ populations. Inhibition of the fetal Hey2+ cell contribution to the hybrid zone
results in persistence of excessive trabeculations in postnatal heart. Our findings indicate
that the expansion of Hey2+ fetal compact component, and its contribution to the hybrid
myocardial zone, are essential for normal formation of the ventricular walls.
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During development of the heart, cardiomyocytes extendinto the ventricular chamber lumen to form a meshworkof trabeculations1–5. During perinatal stages, this
interwoven mesh of muscles undergoes a poorly described
morphogenetic process that results in its disappearance, leaving
behind the postnatal ventricular walls that are largely composed
of compact myocardium, with relatively smooth endocardial
surfaces6. It has often been presumed that perturbation of this
morphogenic process produces so-called left ventricular non-
compaction cardiomyopathy (LVNC), which typically is char-
acterized by the persistence of an excessive lace-like network of
fine trabeculations7, 8. The presence of deep intertrabecular
recesses may lead to cardiac failure, malignant arrhythmias, and
thromboembolism, with the latter process potentially causing
stroke and coronary arterial occlusion9–11. LVNC is now
considered as the third most common type of cardiomyopathy,
affecting up to 0.3% of the general population12, 13. In this setting,
the most luminal component of trabecular meshwork is usually
relatively well compacted, and supports the papillary muscles,
which develop by a process of compaction of pre-existing
trabeculations14. The middle part of the wall, in contrast,
retains a lace-like configuration with deep intertrabecular
endocardial spaces7, 8, 15. Recent studies on LVNC patients, and
also genetic mouse models, showed that thinning of the compact
myocardium is often part of the phenotype9, 16–19, indicating a
reduced proliferation of the cardiomyocytes in the compact layer
is involved in the pathogenesis of LVNC.
Better understanding of the LVNC pathogenesis requires
unraveling the developmental process by which the trabecular
meshwork resolves, and how this resolution is related to the
formation of the mature left ventricular wall. Two mechanisms
for this morphogenic transformation, compact myocardial
expansion and trabecular coalescence, have been hypothesized
(Supplementary Fig. 1a)20. In the compact myocardial expansion
model, it is presumed that the late embryonic or perinatal
expansion of compact myocardium subsequently fills the spaces
within the trabecular meshwork, and gradually shapes these
trabeculations into the solidified compact myocardial wall of the
postnatal heart. The trabecular coalescence model hypothesizes
that the trabeculations expand and coalesce by themselves,
without receiving any significant contribution from the initial
fetal compact myocardium, thus producing in the solidified
compact wall of the postnatal heart. Up untill now, there has been
no direct evidence to distinguish these models.
Here, we used genetic lineage tracing to study the fate of the
embryonic trabecular and compact myocardial components of
the ventricular walls in the postnatal heart. The present study
mainly aims to delineate the cellular process of trabecular
compaction in the developing heart, which provides a basis for
further understanding the pathophysiology of noncompaction.
Results
Nppa and Hey2 are markers for trabecular and compact
myocardium, respectively. We first used scanning electron
microscopy to visualize the changes in myocardial architecture
that occur during the embryonic and neonatal periods. The
trabecular meshwork was readily detected from E10.5 to E14.5.
The meshwork was less obvious in the later embryonic stages, and
had almost disappeared by the neonatal period (Supplementary
Fig. 1b). We next used Nppa and Hey2 as specific molecular
markers for the trabecular and compact layers of the ventricular
myocardium, respectively21. In situ hybridization showed that
Nppa was restricted to the trabeculations, whereas Hey2
was enriched in the compact layer (Fig. 1a, b). We generated an
Nppa-GFP knock-in mouse line (Supplementary Fig. 2a), and
showed that green fluorescent protein (GFP), as a surrogate for
endogenous Nppa expression, was largely restricted to trabecular
cardiomyocytes at E11.5 and E12.5 (Fig. 1c, d and Supplementary
Fig. 2b). The larger part of the left ventricle (LV) trabecular
myocardium expressed GFP, whereas expression in the right
ventricle (RV) trabecular myocardium was less extensive (Fig. 1d
and Supplementary Fig. 2b). Using CRISPR/Cas9 technology, we
generated a Hey2-2A-CreER knock-in allele, in which a Cre
recombinase-estrogen hormone binding domain protein is con-
trolled by Hey2 regulatory elements (Supplementary Fig. 3a).
Immunostaining for the estrogen receptor (ESR) component of
CreER, as a surrogate for endogenous Hey2 expression, con-
firmed that the fusion protein CreER was expressed in the car-
diomyocytes of the compact myocardium of both ventricles,
whereas little expression was observed in the trabecular myo-
cardium (Fig. 1e, f and Supplementary Fig. 3b). The fusion pro-
tein was also highly expressed throughout the forming
interventricular septum at E11.5 and E12.5 (Fig. 1e, f and Sup-
plementary Fig. 3b). Thus, by using Nppa and Hey2, we could
distinguish between trabecular and compact ventricular myo-
cardium in mid-embryonic stages (e.g., E12.5).
Identification of a hybrid myocardial zone in postnatal heart.
To trace the fate of embryonic trabecular cardiomyocytes, we
then generated an Nppa-rtTA mouse line (Fig. 2a), in which the
doxycycline-dependent transactivator rtTA was expressed from
the Nppa locus. To test if this Nppa-rtTA line worked as expected,
we crossed the line with rtTA-responsive reporter lines
TetO-nLacZ22 and TetO-nGFP23 (Fig. 2b). By staining for LacZ
activity or GFP, we found that rtTA expression was largely
restricted to the trabecular myocardium at E12.5 and later time
points, but relatively fewer in the compact myocardium of either
the left or right ventricles (Fig. 2c–e). We next crossed Nppa-rtTA
with TetO-Cre24 and the reporter R26-tdTomato25, permitting
inducible lineage tracing of embryonic trabecular myocardium by
addition of doxycycline at E12.5 (Fig. 3a, b). To provide a more
complete picture of trabecular fate mapping, we analyzed mouse
hearts at multiple time points, specifically E15.5, P0, P3, P7, and
P28 (Fig. 3b). We first detected E15.5 heart section and found that
tdTomato+ cardiomyocytes were enriched in the trabecular
myocardium, but sparsely in the compact layer (percentage of
tdTomato+ cardiomyocytes: 87.81± 3.29% vs. 6.88± 1.10% in
trabecular and compact myocardium respectively, Fig. 3c).
In doxycycline-treated mice, whole-mount images of Nppa-rtTA;
TetO-Cre;R26-tdTomato hearts prepared from E15.5 to postnatal
day 28 (P28) revealed that tdTomato genetic label was restricted
to the subendocardial ventricular myocardium, along with the
atrial myocardium (Fig. 3d, e). Within the ventricular
myocardium of postnatal hearts, tdTomato+ cells were abundant
in the sub-endocardial zones of ventricular free walls, extending
through roughly one-third to one-half of the mural thickness.
Labeling of septal myocardium was less extensive, and was
limited to the subendocardial region (Fig. 3d, e). These data
demonstrate that embryonic trabecular cardiomyocytes
contribute to these labeled sub-endocardial zones of the postnatal
ventricular walls. Magnified images showed that the percentage of
labeled cardiomyocytes in these portions of the ventricular free
walls was high, especially in the papillary muscles (Supplementary
Fig. 4), confirming that they mainly originate from pre-existing
trabecular myocardium. We noticed that the proportions of
labeled cardiomyocytes gradually decreased in the central region
of the ventricular walls of postnatal hearts (Supplementary Fig. 4).
This mosaic region, which we termed “hybrid myocardium”,
likely resulted from Nppa+ cells derived from trabecular
myocardium mixing with unlabeled cells from compact
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myocardium. Alternatively, it is possible that this hybrid
myocardial region might arise from imprecise marking of the
trabecular/compact myocardial boundary by our Nppa-rtTA;
TetO-Cre tracing strategy. This is less likely, as the labeling of
cardiomyocytes at E15.5 is efficient in the trabecular
myocardium, and sparse in the compact myocardium (Fig. 3c and
Supplementary Fig. 4, E15.5), suggesting the gradual dilution of
labeling in the central region of the ventricular walls during
perinatal and postnatal development.
Fetal compact myocardium expands more rapidly than the
trabecular meshwork. To test if unlabeled cells from the compact
myocardium expand into and mix with the trabecular
myocardium, or alternatively, that labeled cells from trabecular
myocardium expand into and mix with the compact
myocardium, we first examined the rate of cardiomyocyte
proliferation in the compact and trabecular components of the
developing heart. By EdU incorporation assay, we detected a
robust proliferation of cardiomyocytes in the compact
myocardium when compared with that observed in the trabecular
myocardium (5.88± 0.31 vs. 18.97± 1.98% in trabecular and
compact myocardium, respectively, Fig. 4a, b). As cardiomyocytes
in the compact myocardium proliferate significantly more than
those making up the trabeculations, it is more likely that
cardiomyocytes of compact myocardium expand into and
intermingle with adjacent trabecular myocardium during the late
embryonic and postnatal stages.
Fetal Hey2+ cardiomyocytes contribute to the postnatal hybrid
myocardial zone. To assess directly the contributions of fetal
compact myocardium to the postnatal ventricular wall, we next
crossed the fetal compact myocardial Cre line Hey2-2A-CreER
(Supplementary Fig. 3a) with R26-tdTomato line25 to trace the
Hey2+ cardiomocytes of the embryonic heart, and collected heart
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Fig. 1 Nppa and Hey2 are expressed in trabecular and compact myocardium, respectively. a Whole-mount and sectional in situ hybridization of Nppa on
E11.5–E13.5 hearts. b In situ hybridization of Hey2 on E11.5–E14.5 heart sections. c Whole-mount fluorescence view of E10.5–E12.5 Nppa-GFP embryos or
hearts. Inserts are bright-field view of embryos or hearts. d Immunostaining for GFP as surrogate for Nppa and cardiomyocyte marker TNNI3 on Nppa-GFP heart
sections showed GFP is restricted to trabecular myocardium. eWhole-mount ESR staining of E10.5–E12.5 Hey2-2A-CreERmice hearts. f Immunostaining for ESR
(as surrogate for Hey2) and TNNI3 on Hey2-2A-CreER heart sections showed ESR expression is enriched in compact myocardium but not in atrial or trabecular
myocardium. Scale bars, 200 µm. Magnified images are shown in Supplementary Fig. 3b. Each image is a representative of four individual samples
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samples at different time points for analysis (Fig. 4c). We also
generated Hey2-2A-CreER;R26-tdTomato;Nppa-GFP mice and
collected heart samples at E13.5. Immunostaining for tdTomato
and GFP, as a surrogate for Nppa, showed that Hey2-2A-CreER
mainly labels the compact layer, and minimally the Nppa+
trabecular layer, whereas GFP is largely restricted in the
trabecular layer and sparsely in the compact layer (percentage of
tdTomato+ cardiomyocytes: 90.31± 2.51 vs. 8.55± 2.39% in the
compact and trabecular myocardium, respectively; percentage of
GFP+ cardiomyocytes: 90.45± 1.09 vs. 3.05± 0.22% in the
trabecular and compact myocardium, respectively; Fig. 4d).
At E15.5, Hey2-2A-CreER had efficiently labeled the compact
myocardium and the interventricular septum, but relatively fewer
cells in the trabecular meshwork (Fig. 4e, f, E15.5). Analysis of
hearts at the later stages of P3, 7, and 28 showed that the compact
cardiomyocytes formed the outer layer of the postnatal
ventricular walls, with few tdTomato+ cells in the papillary
muscles or the inner parts of the walls (Fig. 4f). A substantial
number of tdTomato+ cells were found in the middle part of the
wall adjacent to the bases of the papillary muscles (Fig. 5a and
Supplementary Fig. 5). Quantification of the number of
tdTomato+ cardiomyocytes in the different layers of the
ventricular walls of P3 heart showed <10% of cardiomyocytes
were tdTomato+ cells in the inner layer, over half in the
middle layer, and over 90% in the outer layer, respectively,
taking these layers as representing thirds of the mural thickness
(Supplementary Fig. 5c). This suggests that the fetal Hey2+ car-
diomyocytes form the epicardial layer of the postnatal ventricular
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walls, and contributes to a substantial part of the hybrid region,
but minimally to the endocardial layer, where the papillary
muscles are anchored.
As the arrangement of the cardiomyocytes in the ventricular
walls is oriented three-dimensionally26, we next collected
transverse heart sections from P7 Hey2-2A-CreER;R26-tdTomato
mice, and quantified the number of labeled cardiomyocytes in
each section from base to apex (Fig. 5b). Transverse sections at
different levels of the P7 heart showed that there were three
distinct layers of myocardium in the left ventricle wall: an inner
layer with sparse tdTomato+ cardiomyocytes, a middle hybrid
component with mosaic tdTomato+ cardiomyocytes, and an
outer layer with mostly tdTomato+ cardiomyocytes (tdTomato+
cardiomyocytes: 9.95± 0.58, 45.45± 0.58, and 90.15± 5.20% in
the inner, middle, and outer layer, respectively, Fig. 5c, d),
consistent with the data revealed by the coronal sections
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(Supplementary Fig. 5). The Hey2-2A-CreER had labeled about
half of the cardiomyocytes in the middle hybrid region of the left
ventricular free walls. These data indicate the presence of a hybrid
myocardial zone formed by Nppa+ and Hey2+ cardiomyocytes
that mainly originate from the embryonic trabecular and compact
myocardial regions (Fig. 5e). Immunostaining for Ki67 and
pHH3 showed that there is no significant difference in the
percentage of proliferating cardiomyocytes between tdTomato+
and tdTomato– cardiomyocytes (Fig. 5f, g), indicating these two
populations in the hybrid zone expand equally at P7. Detailed
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gene profile of these tdTomato+ and tdTomato– cardiomyocytes
in the hybrid zone remains a topic for further investigation.
To confirm the above lineage tracing data based on Hey2-2A-
CreER line, which was generated by CRISPR/Cas9 technology27,
we also generated a conventional knock-in Hey2-CreER line by
recombination in ES cells, in which cDNA encoding CreER
fusion protein was inserted into ATG of endogenous Hey2 gene
(Fig. 6a). CreER detected by ESR staining showed its expression
pattern in the compact myocardium from E10.5 through E12.5
(Supplementary Fig. 6), consistent with the Hey2 in situ
hybridization data (Fig. 1b). We treated mice with tamoxifen
and collected hearts at later stages (Fig. 6b). Lineage tracing
experiments based on the Hey2-CreER;R26-tdTomato line
revealed expansion of the pre-labeled compact myocardium
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during development of the ventricular walls (Fig. 6c, d). In
neonatal hearts, Hey2-derived cells make up the majority of
cardiomyocytes in the outer part of the ventricular walls, about
half in the middle parts, and few in the inner components
(Fig. 6e).
The middle part of postnatal ventricular wall includes fetal
trabeculations. The evolution of the trabecular meshwork occurs
concomitant with the formation of coronary vessels during the
perinatal period28. In the embryonic heart, endocardial cells
contribute to a substantial number of coronary endothelial
cells29–31. During perinatal development, these endocardial cells
become entrapped in the trabecular meshwork during a process
in which the intertrabecular spaces are closed, and the myo-
cardium is consolidated32. To explore this accompanying cellular
event further, we used an endocardium inducible Cre line, Npr3-
CreER33. In situ hybridization data demonstrated that Npr3 was
specifically expressed in the endocardium from E12.5 to E14.5
(Supplementary Fig. 7a). Tamoxifen induction of Npr3-CreER;
R26-tdTomato mice in this window had labeled the atrium and
the inner parts of the ventricular walls by P7 (Supplementary
Fig. 7b). These endocardium derived cells contributed to the
majority of the coronary vessels in the inner, but not the outer,
ventricular walls of the postnatal heart (Supplementary Fig. 7c),
suggesting entrapment of endocardial cells between the coalescing
trabeculations during the perinatal period. We also noticed that
endocardial cells contribute to the coronary vessels in the middle
part of ventricular wall (Supplementary Fig. 7c), indicating coa-
lescence of trabecular myocardium in this region. To validate this,
we utilized a Fabp4-Cre line that labels coronary vascular endo-
thelial cells, but not the endocardium34, 35. Using P7 Fabp4-Cre;
R26-tdTomato mice, we could distinguish between endocardial
cells and coronary endothelial cells, both by expression of the
coronary endothelial cell lineage marker (tdTomato), and by the
characteristically different morphology of endocardium as
opposed to coronary microvasculature (Supplementary
Fig. 7d, e). Although most endocardial cells had already adopted a
coronary endothelial cell fate at P7, a subset of endocardial cells
remained in the intertrabecular spaces, which extended deep into
the middle region of ventricular wall (Supplementary Fig. 7d–f).
The presence of this endocardial remnant in the hybrid region of
the postnatal ventricular wall suggests that this region in post-
natal heart was once trabeculated and wrapped in endocardium at
embryonic stages. The middle part of the postnatal ventricular
wall, therefore, includes portions of the trabecular myocardium of
the embryonic heart.
Sema3a+ cells form the innermost layer of the postnatal
ventricular wall. To examine further the potential tripartite
configuration of the postnatal ventricular walls, we generated a
new genetic tool, namely a Sema3a-CreER knock-in allele, to
follow the fate of the innermost trabecular cardiomyocytes of the
postnatal heart (Fig. 7a, b). At E12.5 and E13.5, Sema3a/CreER
was largely expressed in the luminal portions of the meshwork
trabecular myocardium, but rarely in the portions where they
joined the compact myocardium (Fig. 7c). Pulse labeling of
Sema3a-expressing cells at E12.5, followed by chase into the
postnatal heart, showed that the majority of Sema3a lineage of
inner trabecular myocardium contributed primarily to the
innermost sub-endocardial layer and the papillary muscles,
but made minimal contributions to the middle or outer
(sub-epicardial) layers of the ventricular walls (Fig. 7d, e). Fate
mapping data from Nppa, Hey2, Sema3a, as well as endocardial
and coronary vascular lineage tracings, therefore shows that the
innermost Sema3a+ trabeculations make up the sub-endocardial
layer of the mature ventricle wall, including the papillary muscles,
whereas the hybrid myocardium is derived from the compact
myocardium, along with the adjacent portions of trabecular
myocardium (Fig. 7f).
Clonal analysis of Hey2+ cardiomyocyte by single cell lineage
tracing. During Hey2-CreER lineage tracing, we noticed that
8.55± 2.39% of cardiomyocytes in the trabecular myocardium are
tdTomato+ (close to the border between trabecular and compact
myocardium). As genetic lineage tracing depends on the gene
promoter that drives Cre recombinase, it is technically challenging
to achieve clear cut border between two different myocardial
layers. The labeling of Hey2+ cardiomyocytes in the trabecular
layer of fetal heart may confound the interpretation of fate map-
ping result at postnatal stage. To further validate if the compact
myocardial cells of fetal heart contribute to the hybrid middle zone
in postnatal ventricular wall, we employed the single cell clonal
analysis through sparse labeling by the R26-Confetti strategy36.
Crossing of Hey2-CreER with R26-Confetti allele resulted in four
exclusive recombination readouts: nuclear GFP (nGFP), YFP,
RFP, and membrane CFP (mCFP) in Hey2-expressing cells
(Fig. 8a). We injected tamoxifen at low dosage to achieve sparse
labeling at E12.5, and collected heart samples at later stages for
analysis (Fig. 8b). Whole-mount and sectional fluorescence views
of Hey2-CreER;R26-Confetti heart samples showed very sparse
labeling of cardiomyocytes in the compact myocardial wall
(Fig. 8c, d). Almost all of these labeled cardiomyocytes are
restricted to the compact layer, with very sparsely labeled cells in
the trabecular layer or the border region between the compact and
trabecular layers (Fig. 8d, e). In P7 Hey2-CreER;R26-Confetti
heart, we found several isolated clones with multiple cells in each
clone, and all cells in individual clone were of a single color
(Fig. 8f). About half of the clones were within the middle layer,
whereas the other half of the clones were located in the outer layer,
with very few clones detected in the inner layer of the ventricular
wall (Fig. 8g, h). These data from clonal analysis, therefore,
demonstrated that Hey2+ cardiomyocytes in the embryonic
compact myocardium expand and contribute to the hybrid middle
layer of the postnatal ventricular walls (Fig. 8i).
Inhibition of Hey2+ cell expansion produces a non-compacted
hybrid zone. As fetal compact myocardium expands and
intermingles with trabecular myocardium to form the middle
hybrid myocardium of the postnatal heart, we hypothesized that
inhibiting expansion of fetal compact myocardium would result
in abnormal formation of the hybrid myocardium. To inhibit the
expansion of fetal compact myocardium, we ablated Yap1, a
key transcription co-factor, which is required for normal
cardiomyocyte proliferation during cardiac development37–39, in
fetal compact cardiomyocytes using Hey2-CreER and a
conditional Yap1 allele, Yap1flox. Hey2-CreER;Yap1flox/flox
embryos were treated with tamoxifen at E11.5 and E12.5, and
heart samples were collected at P7 (Fig. 9a). Immunostaining for
YAP1 on E15.5 samples showed that, whereas YAP1 expression
was readily detected in trabecular myocardium, it was not
detected in the majority of cardiomyocytes in the compact
myocardium (Supplementary Fig. 8b). Immunostaining for YAP1
on P7 heart sections showed that, whereas YAP1 expression was
readily detected in the inner myocardial wall (IMW), it was
significantly reduced in the outer myocardial wall (OMW) of
Hey2-CreER;Yap1flox/flox-mutant mice compared with
Hey2-CreER;Yap1flox/+ littermate controls (Fig. 9b), indicating
specific ablation of Yap1 in the fetal compact myocardium. As
assessed using hematoxylin and eosin (H&E) staining, there was
extensive non-compacted myocardium in the hybrid zone of
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mutant hearts, but not in control hearts (Fig. 9c). The formation
of the innermost layer, including the papillary muscles, in the
mutant hearts, however, was indistinguishable from that of con-
trols (Fig. 9c). Immunostaining for proliferation marker pHH3
and EdU incorporation showed significantly reduced prolifera-
tion of compact myocardial cardiomyocytes in the mutant hearts
compared with that of controls at E15.5 (pHH3+ cardiomyocytes:
8.28± 1.46 vs. 4.35± 0.45%; EdU+ cardiomyocytes: 18.35± 2.29
vs. 11.50± 1.54% in the mutants and controls, respectively,
Fig. 9d, e and Supplementary Fig. 8). The detection of
proliferating cardiomyocytes in the mutant heart might be due to
the compensatory growth of those Yap1+ cardiomyocytes in the
compact myocardium, as inducible Yap1 deletion by Hey2-CreER
is not complete in all Hey2+ cardiomyocytes in our study.
Examination of trabecular marker connexin 40 (Cx40) or
compact marker Hey2 on the mutant heart section, however,
showed that the trabecular or compact myocardial identity
remains similar in the mutants compared with the controls
(Supplementary Fig. 9). Echocardiography of adult mutant and
control hearts showed a significant reduction of ejection fraction
(EF) and fractional shortening (FS) in the mutant hearts
compared with the controls (EF: 69.66± 5.56 vs. 39.60± 12.55%;
FS: 39.12± 4.86 vs. 19.71± 6.45%; respectively, Fig. 9f), indicat-
ing reduction of heart function in the mutants. Taken together,
these data indicate that expansion of Hey2+ cardiomyocytes is
essential for formation of the hybrid myocardial zone (Fig. 9g).
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Deletion of Yap1 in trabecular layer does not produce a
non-compacted hybrid zone. To further explore if deletion of
Yap1 in trabecular layer would yield the non-compaction
phenotype, we generated Nppa-CreER knock-in allele in which
a CreER is controlled by Nppa regulatory elements (Fig. 10a).
Tamoxifen induction at E11.5-E12.5 in Nppa-CreER;R26-tdTo-
mato specifically labeled the cardiomyocytes in atrial walls and
the trabecular layer of the ventricular walls at E15.5 (Fig. 10b, c).
To delete Yap1 in fetal trabecular myocardium, we crossed Nppa-
CreER with Yap1flox allele to generate Nppa-CreER;Yap1flox/flox
mice (Fig. 10d). Tamoxifen induction at E11.5-E12.5 ablated
Yap1 in the majority of the trabecular cardiomyocytes (Fig. 10e).
Immunostaining for the proliferation marker pHH3 showed that
there was a significant reduction of proliferating cardiomyocytes
in the trabecular myocardium of E15.5-mutant hearts, when
compared with their littermate controls (1.49± 0.10 vs. 2.09±
he
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0.21%; respectively, Fig. 10f, g). Analysis of P7 hearts by H&E
staining, however, showed that there was no observable
non-compacted hybrid zone or thin ventricular wall phenotype in
the mutants, as compared with the littermate controls (Fig. 10h).
These data show that deletion of Yap1 in the trabecular
myocardium does not generate non-compacted myocardium. It is
possible that expansion of compact myocardium to compensate
for the reduced proliferation of cardiomyocytes in the trabecular
myocardium at later embryonic or neonatal stages, or the
compensatory growth of trabecular cardiomyocytes (e.g., from a
few remaining Yap1+ cardiomyocytes), or Yap1 is not required in
the less-proliferating cardiomyocytes in trabecular myocardium
for compaction process.
Discussion
There has been a long debate as to how trabeculations forming
the inner ventricular walls of the developing heart aggregates
together to produce the compact myocardium of the mature
ventricular free walls. Two major models have been advanced to
explain this potential consolidation of trabecular myocardium
into compact muscle (Supplementary Fig. 1a): expansion of
compact myocardium into the trabecular layer (model 1), or
coalescence of trabecular muscles by themselves (model 2). In
both of these two models, compact myocardium expands by itself
to form an increasingly thicker ventricular wall during cardiac
development. The difference between these two models is the
fashion in which the trabecular portion is transformed into
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compacted wall. To resolve this question, we have now used
genetic lineage tracing to track the fates of the Nppa+ and Hey2+
cardiomyocytes, mainly representing fetal trabecular and compact
myocardial components, into the postnatal heart. The fate
mapping results, based on Nppa, Hey2, and Sema3a-driven
genetic labeling, demonstrate that the luminal portions of
the initial trabeculations form the sub-endocardial portion of
the postnatal ventricular wall. The portions of the Nppa+
cardiomyocytes adjacent to the compact myocardium, along with
derivatives of the embryonic compact myocardium itself, then
intermingle to form a middle region of the mature ventricular
wall, which we have dubbed the hybrid myocardial zone. The
embryonic compact myocardium itself then expands significantly
during late embryonic and postnatal stages so as to form the
thickened subepicardial layer of the mature ventricular wall
(Supplementary Fig. 10). The expansion of Hey2+ compact
cardiomyocytes of fetal heart into the trabecular layer to form the
hybrid zone of the postnatal heart was also supported by the
single cell clonal analysis. These fate mapping studies, therefore,
show that our new model is a combination of the two previously
proposed models, differing on the basis of our novel identification
of this middle hybrid zone (Supplementary Fig. 10). When
forming the middle hybrid myocardial zone, it is more likely that
the compact myocardium expands inward, rather than the initial
trabeculations expanding outward, as cardiomyocytes in fetal
compact myocardium proliferate at a significantly greater rate
than those making up the trabecular layer. Our lineage tracing
data based on identification of the ventricular endocardium, as
apposed to the coronary endothelial cells, provided additional
evidence that the anatomic location of hybrid myocardium of
postnatal heart could be traced back to the luminal components
of the trabecular layers of the fetal heart. Although there is
relatively less proliferation rate in trabeculations, their volume
expands with the contribution of proliferating cardiomyocytes
from compact layer, thus facilitating trabecular coalescence for
compaction (Supplementary Fig. 10). During this trabecular
coalescence, trapped endocardial cells give rise to coronary
endothelial cells28.
Our study also provides new evidence that the expansion of
compact myocardium is essential for subsequent trabecular
growth, and its coalescence into compact myocardium. Inhibition
of compact myocardial proliferation by YAP1 ablation resulted in
aberrant formation of the hybrid myocardial zone, with abnormal
persistence of trabeculations and multiple intertrabecular spaces.
These functional data indicate that the trabecular compaction not
only involves the trabecular cardiomyocytes through a process of
coalescence, but also requires the contribution of fetal compact
myocardium. Inhibition of expansion of the fetal compact myo-
cardium also resulted in thinning of the compact ventricular
myocardium, whereas the papillary muscles were formed in
normal fashion. This is consistent with the phenotypic features of
symptomatic individuals with non-compaction cardiomyopathy,
in which excessive trabeculations are associated on occasion with
thinning of the compact myocardium, but without severe defects
in the papillary muscles7, 8. Our study thus suggests that non-
compaction may not be attributed to a defect exclusively invol-
ving the trabeculations themselves. The compact myocardium
continues to contribute substantially to formation of a major part
of the ventricular wall in the late embryonic and early neonatal
stages, with compression of intertrabecular spaces serving to form
the middle hybrid zone of the ventricular wall.
Most studies have suggested that noncompaction is persistence
of excessive trabeculation rather than reduced resolution of
compaction. Our study now suggests that, in addition to potential
excessive trabeculation, there is a specific morphogenic process
that may be perturbed, which then recapitulates the phenotypic
features. The contribution made by the Hey2+ lineages of
compact myocardium to the trabecular layer expands the
myocardial volume, compressing the intertrabecular spaces in this
middle region and consolidating the walls concomitant with the
formation of the coronary vasculature. Re-examination of the
anatomic features of many individuals with the noncompaction
phenotype permits recognition of a tripartite configuration of the
ventricular walls7, 8, 15, in which the middle part of the wall retain
a lace-like configuration, with deep intertrabecular spaces as part
of the meshwork. In addition, thinning of the compact
myocardium is typically a feature of symptomatic individuals
having excessive trabeculations9, 16, 17, and also in most
animal models thus far considered to show the non-compaction
cardiomyopathy18, 19. These lines of evidence emphasize the
critical role of proliferation and expansion of Hey2+ lineages of
compact layer for trabecular compaction. The identification of
this middle hybrid component of the myocardial wall, as well as
the contribution of compact myocardium to the phenotype of
excessive trabeculations, provides a basis for further under-
standing the pathophysiology of noncompaction. The genetic
tools generated in this study have now helped to dissect the
molecular mechanisms regulating trabecular compaction. Recent
work showed that Dll4-Notch1 signaling induce trabecular
formation and later coordinate its patterning and compaction
with coronary vessel formation to generate the mature
chamber40, 41, so it remains a fascinating question of how Hey2+
or Nppa+ lineages are directly affected in Dll4-Notch mutant.
More broadly, it will be important to understand in detail how
different signaling pathways converge to regulate the trabecular
compaction, such as the Dll4-Notch40, 41, Mib117, BMP42, and
TGF-β119 pathways, all of which have previously been proposed
to be involved in the LVNC.
Methods
Mice. All mice were used in accordance with the guidelines of the Institutional
Animal Care and Use Committee of the Institute for Nutritional Sciences, Shanghai
Institutes for Biological Sciences, Chinese Academy of Sciences. Mice were
maintained on a C129/C57BL6/J mixed background. Both male and female mice
were randomized in different experiment groups in this study. Doxycycline (Sigma)
was dissolved in 50% ethanol and introduced by gavage at indicated time (0.2–0.25
mg/g). Tamoxifen was dissolved in corn oil, 4-hydroxytamoxifen (Sigma) was
dissolved in 25% ethanol-corn oil, and introduced by gavage at indicated time
(0.01–0.1 mg/g)43. TetO-LacZ, TetO-GFP, TetO-Cre, Fabp4-Cre, R26-tdTomato,
R26-Confetti, and YAP1 were described previously22–25, 34, 36, 44. Nppa-GFP,
Nppa-rtTA, Hey2-CreER, and Sema3a-CreER lines were generated by homologous
recombination using Red/ET recombineering as previously described45. For
Nppa-GFP and Nppa-rtTA mouse lines, cDNAs-encoding DTRGFP fusion
protein46, or rtTA were inserted into frame with the translational start codon of the
Nppa gene. For Nppa-CreER allele, a cDNA encoding Cre recombinase fused with
a mutant form of the estrogen receptor hormone-binding domain (CreERT2)47 was
inserted into the translational stop codon of Nppa gene (before 3′ UTR), with a
self-cleaving 2 A peptide sequence linking Nppa and CreER. For Hey2-CreER,
Npr3-CreER, and Sema3a-CreER mouse lines, a cDNA encoding Cre recombinase
fused with a mutant form of the estrogen receptor hormone-binding domain
(CreERT2)47 was inserted in frame with the translational start codon of the Hey2,
Npr3, or Sema3a gene. After G418 selection, over 100 clones were selected for
retrieval of genomic DNA and screening of positive clones. To screen the correct
targeted clones, we used long PCR assays with primer pairs spanning the targeting
vector and flanking genomic DNA according to standard protocols48. After
validation of correct targeting and normal karyotype, we expanded at least three
positive ES clones for each line and injected ES cells into blastocysts for mice
generation. The obtained chimeric mouse lines were crossed to C57B/6 lines for
germline transmission. Hey2-2A-CreER line was generated by homologous
recombination using CRISPR/Cas9 technology (gRNA sequence: 5′-AGATTCA
AGAATAAGTTAAA-3′ and 5′-GTAACTGATGTCGTCCATTT-3′) according to
published protocols49. For Hey2-2A-CreER line, a cDNA encoding CreERT2
followed by a polyadenylation sequence was inserted into the last coding exon of
Hey2 gene. A P2A peptide sequence was included in the targeting vector to link
Hey2 coding region (before translational stop codon) and CreERT2 cDNA, thus
allowing expression of both Hey2 and CreERT2 proteins. These seven knock-in
mice lines (Nppa-GFP, Nppa-rtTa, Nppa-CreER, Hey2-CreER, Hey2-2A-CreER,
Npr3-CreER, and Sema3a-CreER) were generated by Shanghai Biomodel Organism
Science & Technology Development Co. Ltd.
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Electron microscopy. The preparation of samples for electron microscopy was
done according to protocols described previously50. Briefly, embryonic hearts from
timed pregnancies and neonatal hearts of P0, P3, and P7 were dissected in PBS and
fixed overnight in 4% paraformaldehyde (PFA) in PBS at 4 °C. After wash with PBS
for three times, hearts were transferred to 30% sucrose for overnight cryopre-
servation at 4 °C and embedded in OCT. Blocks were sectioned to reveal the
transverse plane of ventricle. The blocks were dissolved in PBS at room temperature
and post-fixed in 5% acetic acid, 3.7% formaldehyde, and 50% ethanol. Then the
sectioned hearts were dehydrated in gradient concentrations of ethanol from 50 to
100% at successive 10% increment. Liquid carbon dioxide was used for critical point
drying. The dry specimens were mounted on stubs and sputter-coated with gold
before observation with a FEI Quanta 250 scanning electron microscope.
RNA in situ hybridization. Whole-mount RNA in situ hybridization was carried
out as described previously51. Briefly, whole-dissected embryonic hearts were fixed
in 4% PFA in DEPC-treated PBS overnight. After washing in diethyl pyrocarbonate
(DEPC)-treated PBS, fixed embryonic hearts were dehydrated through a graded
methanol (25, 50, 75, and 100% methanol in DEPC-treated PBS) for 5 min each on
ice with rotation. Treated samples could be stored at −20 °C for a couple of weeks.
After dehydration, the embryonic hearts should be rehydrated through 100, 75, 50,
and 25% methanol, and rinsed in DEPC-treated PBS. After bleached in 6%
hydrogen peroxide that was diluted in DEPC-treated PBS, the embryonic hearts
were digested with Proteinase K at a concentration of 20 µg/ml for 10 to 30min at
room temperature. Embryonic hearts were re-fixed with 0.2% glutaraldehyde and
4% PFA for 20min at room temperature, followed by washing three times with 0.1%
tween20 in PBS for 5 min each time and incubation in hybridization buffer for 1 h at
70 °C. Then embryonic hearts were transferred into fresh hybridization buffer
containing 1 µg/ml digoxigenin UTP-labeled RNA probes and incubated overnight
with rocking at 70 °C. After washing in different wash solution buffers and being
treated with ribonucleases to remove redundant probes, the embryonic hearts were
incubated with anti-digoxigenin alkaline phosphatase (AP)-conjungated antibody
(Roche, 11093274910, 1:2000) overnight with rocking at 4 °C. The embryonic hearts
were washed with 2mM levamisole in mixture of Tris-buffered saline and Tween 20
(TBST) for a whole day to remove the residual antibody and inhibit endogenous AP
activity. AP activity for probe detection was developed in BM purple (Roche,
11442074001) in dark until the color has been developed to the desired extent.
Sectional in situ hybridization was carried out according to published protocols52. In
detail, dissected embryos were fixed overnight in 4% paraformaldehyde and
embedded in optimal cutting temperature (OCT, Sakura). Embryos were sectioned
at 10 µm thickness. Slides were hybridized overnight with 1 µg/ml probes at 65 °C.
After washing in salt sodium citrate (SSC) buffer and treated with ribonucleases at
37 °C for 30min, slides were incubated with alkaline phosphatase coupled anti-
digoxigenin antibodies overnight. BCIP/NBT (Promega, S3771) were used to
develop the color in dark to the desired extent. Then slides were mounted with
glycerol and images were acquired by Olympus microscope (BX53). The primers
used for in situ hybridization were listed in Supplementary Table 1.
X-gal staining. Embryonic hearts from timed pregnancies were fixed in LacZ fix
solution (0.2% glutaraldehyde, 5 mM EGTA, 100 mM MgCl2 in PBS) for 10 to 20
min based on the size. After washing three times for 15 min in LacZ wash buffer
containing 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40 in 100 mM
sodium phosphate buffer, specimens were embedded in OCT. Embryonic hearts
were sectioned at 10 µm thickness. Slides were stained in LacZ stain solution
containing 1 mg/ml 5-bromo-4-chloro-3-indolyl β-D galactopyranoside (X-gal) in
LacZ wash buffer at 37 °C to the desired extent. Then slides were mounted with
glycerol and images were acquired by Olympus microscope (BX53).
Immunostaining. Immunostaining was performed as according to standard pro-
tocols53. In detail, embryos and postnatal hearts were collected and washed in PBS
on ice, and then fixed in 4% PFA at 4 °C for 15min to 1 h based on the size of
tissues. After three washings in PBS, embryos and hearts with fluorescence reporters
were observed and photographed using Zeiss stereomicroscope (Zeiss AXIO Zoom.
V16). The embryos and hearts were dehydrated in 30% sucrose in PBS overnight at
4 °C, then embedded in OCT and snap frozen. Cyrosections collected at 10 μm
thickness were air dried for 30min to 1 h at room temperature. Tissues were blocked
with PBS supplemented with 0.2% triton X-100 and 5% normal donkey serum
(Jackson ImmunoResearch, 017-000-121) for 30min at room temperature, followed
by first antibody incubation at 4 °C overnight. We used commercial antibodies for
detection of endogenous antigens: GFP (Invitrogen, A21311, 1:200), ESR (Abcam,
ab27595, pre-diluted), tdTomato (Rockland, 600-401-379, 1:1000), TNNI3 (Abcam,
ab56357, 1:200), YAP1 (Cell signaling technology, 4912 S, 1:200), pHH3 (Millipore,
06-570, 1:1000), Ki67 (Thermo scientific, RM-9106-S0, 1:100), PECAM (BD
PHharmingen, 553370, 1:500), Cx40 (Alpha Diagnostic International, CX40-A,
1:100), and EdU (Invitrogen, C10337). Signals were developed with Fluorescence-
conjugated Alexa donkey anti rabbit and goat secondary antibodies (Invitrogen,
1:1000) for 30min at room temperature. For weak signals, we used HRP-conjugated
or biotin-conjugated antibodies with tyramide signal amplification kit
(PerkinElmer)54. Before coverslip addition, tissues were counterstained with
mounting medium with 4′6-diamidino-2-phenylindole (DAPI, Vector lab, H-1200).
Immunostaining images were acquired by Olympus fluorescence microscope
(BX53), Zeiss stereomicroscope (AXIO Zoom. V16), Zeiss confocal laser scanning
microscope (LSM510) and Olympus confocal microscope (FV1200). Quantification
of proliferating cardiomyocytes was done by an analyzer who was blinded to the
experimental groups.
Whole-mount estrogen receptor staining. Whole-mount estrogen receptor (ESR)
staining was performed according to the protocol for whole-mount PECAM
staining55. Briefly, embryos were collected in PBS on ice and fixed in 4% PFA in PBS
overnight at 4 °C. After washing three times in PBS, embryos were dehydrated
through a methanol gradient (25, 50, 75, and 100% methanol in PBS) for 15min
each at room temperature. Embryos were bleached in 5% hydrogen peroxide in pure
methanol for 2 h at 4 °C to inhibit endogenous peroxidase activity. Then the
embryos were rehydrated through 100, 75, 50, and 25% methanol in PBS for 10min
each at room temperature. For embryos with tails covering part of heart surface,
tails were removed before staining. Embryos were blocked in PBS-containing 0.1%
Triton X-100 and 5% normal donkey serum for 1 h at 4 °C. Samples were then
incubated in block solution containing 50% ESR antibody (Abcam, ab27595)
overnight at 4 °C, followed by five times wash in PBS-containing 5% normal donkey
serum. Samples were then incubated with secondary antibody anti-rabbit con-
jugated with peroxidase (Vector lab, 1:500) in blocking solution for 10 h, followed
by five times PBS-containing 5% normal donkey serum wash. Finally, embryos were
developed by chromogen DAB (Vector Lab) at room temperature to the desired
extent. Images were taken under Leica stereomicroscope (M165 FC).
Echocardiography. Echocardiographic measurements were performed on adult
mice, which were anesthetized with isofluorane via a digital ultrasound system (Vevo
2100 Imaging System, Visual Sonics). Heart rate and LV dimensions, including
diastolic and systolic wall thicknesses and LV end-diastolic and end-systolic chamber
dimensions, were measured from two-dimentional short-axis views under M-mode
tracings at the level of the papillary muscle. LV mass and functional parameters,
such as percentage of fractional shortening (FS) and ejection fraction (EF), were
calculated using the above original parameters and accompanying software.
Statistics. Data for two groups were analyzed by an unpaired student’s t test,
whereas comparison between more than two groups was performed using an
ANOVA followed by Tukey’s multiple comparison test. Significance was accepted
when P< 0.05. All data are presented as mean ± SEM.
Data availability. Data supporting the findings of this study are available within
the article and its Supplementary Information files, and from the corresponding
author upon reasonable request.
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